Market Overview

Revance Therapeutics (NASDAQ: RVNC)

18.11 -2.08 (-10.30%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/16/18GuggenheimUpgradesBuy41.0
9/17/18JMP SecuritiesDowngradesMarket Perform0.0
3/05/18Goldman SachsInitiates Coverage OnBuy60.0
1/09/18GuggenheimDowngradesNeutral
12/06/17GuggenheimInitiates Coverage OnBuy42.0
11/27/17BarclaysInitiates Coverage OnOverweight31.0
11/17/17MizuhoInitiates Coverage OnBuy37.0
8/22/17JMP SecuritiesInitiates Coverage OnMarket Outperform34.0
7/21/17Cantor FitzgeraldInitiates Coverage OnOverweight50.0
11/29/16Aegis CapitalInitiates Coverage OnBuy28.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter